2
Supported by Amgen Med Ed Matters is an authorised provider of Accredited Activities under the RACGP QI&CPD Program. WHY YOU SHOULD ATTEND: Enhance your skills in the management of osteoporosis Develop your ability to prioritise chronic diseases Gain practice insights from a local osteoporosis expert ALL WHILE: Earning 40 (category one) points in the RACGP QI&CPD Program (or ACRRM equivalent) Developing strategies to improve practice efficiency and patient outcomes YOUR INVITATION TO REFERENCES: 1. Watts J, et al. Osteoporosis costing all Australians: A new burden of disease analysis 2012 to 2022. 2013 Osteoporosis Australia. 2. PBS criteria for treatment. Available from http://www.pbs.gov.au. 3. Henry MJ, et al. J Clin Densitom 2000;3:261–68. 4. Medicare Australia dataset (2018/MI8392), received 05/18. Analysis of a 10% sample from a total sample of 82,677 initiations. © 2019 Amgen Australia Pty Ltd Level 7, 123 Epping Road, North Ryde NSW 2113. Tel: +61 (2) 9870 1333 | Fax: +61 (2) 9870 1344. ABN 31 051 057 428. AU-10374 December 2018 Amgen Australia collects your personal information to enable us to manage and promote our educational events and educational events convened by other organisations, follow up with you about your experience at these events and engage with you for the purpose of our promotional activities. For this purpose, we may disclose your personal information to Amgen Australia’s related entities, as well as to trusted third parties and suppliers who assist us in providing our products and services, and market research agencies. These related entities and third parties may be located in other countries including the United States of America and in Europe and Asia. Amgen Australia remains accountable for all personal information it discloses and takes appropriate measures to ensure that the confidentiality of your information ais safeguarded. For more information on privacy at Amgen Australia, please see our privacy policy available at www.amgen.com.au/privacy/privacy_terms.html or contact our Privacy Officer—Mail: Attn: Privacy Officer, Amgen Australia Pty Ltd Level 7, 123 Epping Road, North Ryde NSW 2113 Email: privacyoffi[email protected] Tel: +61-2-9870-1333 www.criticalconsultations.com.au | Password: CRITICAL Secure your place. Register now. Opportunity to convert to QI activity Additional 5 CPD points A Category 1 RACGP-accredited program to improve outcomes in osteoporosis ONLY 4 out of 10 patients at HIGH RISK OF FRACTURE are receiving long-term treatment 1-4

A Category 1 RACGP-accredited program to improve—outcomes ... · Amgen Australia collects your personal information to enable us to manage and promote our educational events and

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: A Category 1 RACGP-accredited program to improve—outcomes ... · Amgen Australia collects your personal information to enable us to manage and promote our educational events and

Supported by Amgen

Med Ed Matters is an authorised provider of Accredited Activities under the RACGP QI&CPD Program.

WHY YOU SHOULD ATTEND: ▶ Enhance your skills in the management of osteoporosis ▶ Develop your ability to prioritise chronic diseases ▶ Gain practice insights from a local osteoporosis expert

ALL WHILE: ▶ Earning 40 (category one) points in the

RACGP QI&CPD Program (or ACRRM equivalent) ▶ Developing strategies to improve practice efficiency

and patient outcomes

YOURINVITATION TO

REFERENCES: 1. Watts J, et al. Osteoporosis costing all Australians: A new burden of disease analysis 2012 to 2022. 2013 Osteoporosis Australia. 2. PBS criteria for treatment. Available from http://www.pbs.gov.au. 3. Henry MJ, et al. J Clin Densitom 2000;3:261–68. 4. Medicare Australia dataset (2018/MI8392), received 05/18. Analysis of a 10% sample from a total sample of 82,677 initiations.

© 2019 Amgen Australia Pty Ltd Level 7, 123 Epping Road, North Ryde NSW 2113. Tel: +61 (2) 9870 1333 | Fax: +61 (2) 9870 1344. ABN 31 051 057 428. AU-10374 December 2018

Amgen Australia collects your personal information to enable us to manage and promote our educational events and educational events convened by other organisations, follow up with you about your experience at these events and engage with you for the purpose of our promotional activities. For this purpose, we may disclose your personal information to Amgen Australia’s related entities, as well as to trusted third parties and suppliers who assist us in providing our products and services, and market research agencies. These related entities and third parties may be located in other countries including the United States of America and in Europe and Asia. Amgen Australia remains accountable for all personal information it discloses and takes appropriate measures to ensure that the confi dentiality of your information ais safeguarded. For more information on privacy at Amgen Australia, please see our privacy policy available at www.amgen.com.au/privacy/privacy_terms.html or contact our Privacy Offi cer—Mail: Attn: Privacy Offi cer, Amgen Australia Pty Ltd Level 7, 123 Epping Road, North Ryde NSW 2113 Email: privacyoffi [email protected] Tel: +61-2-9870-1333

www.criticalconsultations.com.au | Password: CRITICAL

Secure your place. Register now.

Gain practice insights from a local osteoporosis expert

Opportunity to convert to

QI activity

Additional5 CPD points

A Category 1 RACGP-accredited program to improve outcomes in osteoporosis

ONLY 4 out of 10 patients at HIGH RISK OF FRACTURE arereceiving long-term treatment1-4

AU-10374 CCiO invitation template.indd 1 20/12/2018 11:09 AM

Page 2: A Category 1 RACGP-accredited program to improve—outcomes ... · Amgen Australia collects your personal information to enable us to manage and promote our educational events and

P L A C E S A R E L I M I T E D . L E T U S S E C U R E Y O U R S .

Any questions? Contact your local AMGEN representative

Register now atwww.criticalconsultations.com.au

Password: CRITICAL

REGISTER

NOW

Upon registration you will receive an email confi rmation with further information about the activity. An email and SMS reminder will also be sent

closer to the meeting date. Should you require further information regarding your registration, please contact the secretariat: Phone: 0419 221 808

Fax: 02 8583 3061 Email: [email protected]. In accordance with the Code of Conduct for the prescription medicines industry in Australia,

any costs (e.g. travel or meals) incurred by a partner/spouse, guest or family member travelling with you will not be paid for or subsidised by Amgen.

4 hour workshop & 2 hour practice activity

For more information visitwww.criticalconsultations.com.au

Password: CRITICAL

YOUR

LOCALWORKSHOP

▶ Negotiating priorities in chronic disease management▶ Who is at risk of fracture?▶ Critical consultation: identifying osteoporosis▶ Osteoporosis management options▶ Critical consultation: initiating an osteoporosis

management plan▶ Long-term management of chronic disease▶ Critical consultation: evaluating long term management

T O P I C S C O V E R E D

LUNCH ON ARRIVAL • AFTERNOON TEA PROVIDED

AU-10374 CCiO invitation template.indd 2 20/12/2018 11:09 AM

Dr Devina Joshi

Dr Jay Ruthnam

Saturday30 March 2019

12.00pm to 5.00pm

Please RSVP by: 25 March 2019

Peter Grudzinskas on 0428 149 980

Pacific BayConference CentreCnr Pacific Highway andBay DriveCoffs Harbour NSW2450

Endocrinologist, Coffs Medical Specialists, Coffs Harbour, NSW

General Practitioner